Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
BioNTech SE
NRG Oncology
EpicentRx, Inc.
Alliance for Clinical Trials in Oncology
RTOG Foundation, Inc.
UNICANCER
Fuzhou General Hospital
SWOG Cancer Research Network
Radiation Therapy Oncology Group
Radiation Therapy Oncology Group
Case Comprehensive Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Swami Rama Cancer Hospital and Research Institute
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University College, London
National Cancer Institute (NCI)